Elderly nutrition market

Elderly Nutrition Market, by Nutrition Type (Minerals, Multi-Vitamins, Iron, Proteins, Fibers, Lipids, Antioxidants, and Others), by Application (Diabetes, Renal Failures, Obesity, Sarcopenia, Cancer, and Others), by Route of Administration (Oral, Parenteral, and Enteral), by Distribution Channel (Hospitals & Clinics, Retail Pharmacies, Convenience Store, Online, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Request Free Sample

Aug 2022
CMI2437
174 Pages
Excel & Pdf
Pharmaceutical

Summary

Elderly nutrition plays a major role in advance healthcare in geriatric segment, as it supports healthy aging and prevents malnutrition and vitamin deficiencies. Elderly nutrition products consist of vitamins, proteins, minerals, lipids, fibers, and other essential substances, which regulate the body functions and improve immunity. Nutrition is a key determinant of geriatric mass, particularly in people over 60. Getting enough nutrients is important for healthy ageing. Physical exercise is another activity that contributes to making ageing process easy. Before beginning any form of physical activity, it is important to examine health issues such hypertension, cholesterol, renal failure, joint problems, and heart issues. Any type of physical illness should be treated with therapeutic diets.

Global elderly nutrition market size was valued at US$ 23,632.4 million in 2022 and is expected to witness a CAGR of 6.7% over the forecast period (2022 – 2030).

Figure 1. Global Elderly Nutrition Market Share (%), by Nutrition Type, 2022

Increasing preference for protein supplements for proper nutritional value is expected to drive the elderly nutrition market growth over the forecast period.

Increasing preference for protein supplements for proper nutritional value is expected to drive the market growth over the forecast period. For instance, in December 2021, according to the reports published in National Center for Biotechnology Information, a National Library of Medicine, published a report on Rational Use of Protein Supplements in the Elderly—Relevance of Gastrointestinal Mechanisms, which stated that the nutritional supplements, including pure-protein or protein-enriched drinks, are increasingly used by older people to maintain body weight and nutrition, and specifically to prevent or treat loss of muscle function, sarcopenia, and frailty. Protein supplements appear relatively safe, although care should be taken in those with or at risk of renal impairment, or prone to post-nutrient hypotension.

Elderly Nutrition Market Report Coverage

Report Coverage	Details
Base Year:	2021	Market Size in 2022:	US$ 23,632.4 Mn
Historical Data for:	2017 to 2022	Forecast Period:	2022 to 2030
Forecast Period 2022 to 2030 CAGR:	6.7%	2030 Value Projection:	US$ 39,594.2 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Nutrition type: Minerals, Multi-Vitamins, Iron, Proteins, Fibers, Lipids, Antioxidants, Others(Carbohydrates, Zinc, etc) By Application: Diabetes, Renal Failures, Obesity, Sarcopenia, Cancer, Others(Cardiovascular Disease, Osteoporosis, etc) By Route of Administration: Oral, Parenteral, Enteral By Distribution Channel: Hospitals & Clinics, Retail Pharmacies, Online Pharmacies, Others(Hypermarket, Supermarket, etc)
Companies covered:	Otsuka Pharmaceuticals Co., Ltd., Baxter International Inc., Allergan, Danone, Abbott Laboratories, Pfizer, Inc., Mead Johnson & Company, LLC., Sanofi, Nestlé’s, GlaxoSmithKline, Fresenius Kabi AG, Ranbaxy, WOCKHARDT, The Kraft Heinz Company, and Sichuan Kelun Pharmaceutical Company Limited.
Growth Drivers:	Increasing preference of protein supplements for proper nutritional value Increasing incidences of chronic diseases in geriatric patients
Restraints & Challenges:	Increasing number of side effects and complications associated with parenteral administration

Figure 2. Global Elderly Nutrition Market Share (%), by Region, 2022

Increasing incidences of chronic diseases in geriatric patients is expected to propel growth of the elderly nutrition market.

Increasing prevalence of respiratory infections in the U.S. is expected to drive market growth over the forecast period. For instance, in June 2021, The Centers for Disease Control and Prevention, a national public health agency of the U.S. stated that each year in the U.S., RSV (Respiratory Syncytial Virus) leads to approximately 58,000 hospitalizations with 100-500 deaths among children younger than 5 years old and 177,000 hospitalizations with 14,000 deaths among adults aged 65 years or older. Infants, young children, and older adults with chronic medical conditions are at risk of severe diseases from RSV (Respiratory Syncytial Virus) infection.

Global Elderly Nutrition Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.The sudden outbreak of COVID-19 has bought the world to a standstill.

Increasing use of nutraceuticals and dietary supplements for older adults to recover from Covid-19 has boosted growth of the global elderly nutrition market. For instance, in June 2022, Clinics in Geriatric Medicine, a diagnostic and therapeutic information center, published a report on Nutraceuticals and Dietary Supplements for Older Adults with Long COVID-19, which stated that age group of older adults has been effected most during covid-19. Long COVID has a complex pathophysiology encompassing inflammatory and autoimmune processes, perturbations in metabolic pathways, and alterations in endothelial function and redox homeostasis. The management of long COVID requires a multidimensional approach that should include a comprehensive nutritional assessment. Several food bioactive compounds, nutraceuticals, and supplements may target specific pathways involved in long COVID and may, therefore, be used as an adjunctive therapy to manage the condition.

Global Elderly Nutrition Market: Key Developments

For instance, in February 2019, Danone, a multinational food-products company, launched high protein nutrition drink with zero sugar, it provides the benefit of both High Protein and zero sugar. Protinex Lite comes with a formulation of Zero Sugar, Low glycemic diet, High Fibre and 27 vital nutrients with an aim to address protein deficiency. The launch would help the company in further expansion in dietary supplements.
In June 2020, Arla Foods Ingredients, a whey ingredient supplier, had launched a new whey protein ingredient Lacprodan HYDRO.Rebuild, which is clinically proven to counteract age-related muscle mass decline. It offers highly accessible content of branched-chain amino acids and essential amino acids such as leucine, which are important for muscle synthesis in seniors and also helps in improvement of muscle mass, strength and mobility.

Elderly Nutrition Market Restraints

The routes of administration such as oral, parenteral, and enteral are very important for administration of nutrition in the elder patients. However, parenteral route of administration has to be performed under medical supervision, to avoid side effects and complications, which burdens cost on geriatric patients. The incorrect use of this therapy from parenteral route can cause liver dysfunction, refeeding syndrome, and other side effects.

Key Players

Key players operating in the global elderly nutrition market include Otsuka Pharmaceuticals Co., Ltd., Baxter International Inc., Allergan, Danone, Abbott Laboratories, Pfizer, Inc., Mead Johnson & Company, LLC., Sanofi, Nestlé’s, GlaxoSmithKline, Wockhardt Ltd, Fresenius Kabi AG, Ranbaxy, WOCKHARDT, The Kraft Heinz Company, and Sichuan Kelun Pharmaceutical Company Limited.

Table of Content

Table of Contents

*Browse 30 market data tables and 28 figures on “Elderly Nutrition Market” - Global forecast to 2030

Segmentation

Detailed Segmentation:

- Frequently Asked Questions -

What are the growth estimates for global elderly nutrition market till 2030?

Global elderly nutrition market is estimated to surpass US$ 39,594.2 million by 2030

Which are the prominent elderly nutrition market players across the globe?

Major players operating in the market include Otsuka Pharmaceuticals Co., Ltd., Baxter International Inc., Allergan, Danone, Abbott Laboratories, Pfizer, Inc., Mead Johnson & Company, LLC., Sanofi, Nestlé’s, GlaxoSmithKline, Wockhardt Ltd, Fresenius Kabi AG, Ranbaxy, WOCKHARDT, The Kraft Heinz Company, and Sichuan Kelun Pharmaceutical Company Limited.

Which segment based on nutrition type, accounted for the highest demand in market of elderly nutrition in 2022?

Among Nutrition type, protein segment generated significant revenue in 2022, owing to increasing preference of protein supplements for proper nutritional value.

What are the key factors driving growth of the market?

Increasing preference of protein supplements for proper nutritional value is expected to drive the market growth over the forecast period.

What is the Compound Annual Growth Rate (CAGR) of the market till 2030?

The market is estimated to exhibit a CAGR of 6.7% over the forecast period.

Which region is dominating the market growth?

Among regions, North America is expected to witness significant growth over the forecast period, owing to increasing prevalence of chronic diseases in the U.S.